Revolutionizing Early Diagnostics with Mirror-Image Nanopores
Scientists at BRIC-RGCB have created mirror-image synthetic peptides that mimic natural protein tunnels. These advanced nanopores hold promise for early cancer detection and personalized diagnostics. Researchers, led by Dr. Mahendran K R, discovered their potential in selectively targeting cancer cells, offering new diagnostic and treatment avenues.

- Country:
- India
In a groundbreaking development, scientists at BRIC-RGCB have engineered "mirror-image" nanopores utilizing synthetic peptides. These novel structures imitate natural protein tunnels but exhibit enhanced stability and selectivity.
Under the leadership of Dr. Mahendran K R, these advanced nanopores, termed DpPorA, could significantly advance early diagnostics for diseases like cancer. This achievement, published in Nature Communications, represents a collaboration across multiple research institutions and is a stride towards personalized medical solutions.
The innovative design allows only specific biomolecules to pass through, offering potential for precise cancer therapies. Initial tests revealed the nanopores' ability to selectively damage cancer cells without harming healthy ones, marking a promising leap forward in diagnostic technology.
(With inputs from agencies.)